Insider Transactions in Q1 2022 at Catalent, Inc. (CTLT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2022
|
Peter Zippelius Director |
SELL
Open market or private sale
|
Indirect |
487,092
-10.11%
|
$49,683,384
$102.65 P/Share
|
|
Jan 31
2022
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Open market or private sale
|
Direct |
2,325
-11.99%
|
$239,475
$103.39 P/Share
|
|
Jan 21
2022
|
Ricci S Whitlow President, CSS |
SELL
Open market or private sale
|
Direct |
184
-5.92%
|
$18,768
$102.37 P/Share
|
|
Jan 10
2022
|
Karen Flynn Director |
SELL
Open market or private sale
|
Direct |
2,472
-6.93%
|
$286,752
$116.64 P/Share
|
|
Jan 03
2022
|
Jonathan Arnold SVP, CCO & Div. Head BioP Del. |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+8.03%
|
-
|
|
Jan 03
2022
|
Steven L Fasman EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+6.16%
|
-
|
|
Jan 03
2022
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+6.13%
|
-
|
|
Jan 03
2022
|
Michael J Grippo SVP, Strategy & Corp. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+19.56%
|
-
|
|
Jan 03
2022
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+15.39%
|
-
|
|
Jan 03
2022
|
Ricardo Pravda Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,017
+20.31%
|
-
|